类风湿关节炎的生物治疗进展
Advance of biological therapy in rheumatoid arthritis
出处
《实用医学杂志》
CAS
2005年第13期1373-1375,共3页
The Journal of Practical Medicine
参考文献13
-
1van der Heijde DM. Joint erosions and the patient with early rheumatoid arthritis. Br J Rheumatol, 1995, 34(Suppl 2):74-78
-
2Dougados D, Suurmeijer T, Krol B, et al. Work disability in early rheumatoid arthritis. Ann Rheum Dis, 1995, 54(6): 445-60
-
3Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p 75)- Fc fusion protein. N Engl J Med, 1997, 337(3): 141-147
-
4Moreland LW, Schiff MH, Baumgartner SW, et al. Etanercept therapy in rheumatoid arthritis: a randomized controlled trial. Ann Intern Med, 1999, 130 (6): 478-486
-
5Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med, 1999, 340 (4): 253-259
-
6Moreland LW, Cohen SB, Baumgartner SW, et al. Longterm safety and efficacy of etanercept in patients with rheumatoid arthritis. J Rheumatol, 2001, 28(6): 1238-1244
-
7Elliott MJ, Maini RN, Feldmann M, et al. Randomized double blind comparison of chimeric monoclonal antibody to tumour necrosis factor- a (cA2) versus placebo in rheumatoid arthritis. Lancet, 1994, 344(8930): 1105-1110
-
8Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti- tumor necrosis factor a monoclonal antibody combined with low- dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum, 1998, 41(9): 1552-1563
-
9Rau R. Adalimumab (a fully human anti- tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials. Ann Rheum Dis, 2002, 61(Suppl. 2): ii70-ii73
-
10Weinblatt ME, Keystone EC, Furst DE. Adalimumab, a fully human anti- tumor necrosis factor- a monoclonal antibody for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum, 2003, 48(1): 35-45
-
1尤翠兰.厄贝沙坦联合复方丹参滴丸治疗高血压左心室肥厚[J].中国卫生产业,2014,11(11):89-90. 被引量：5
-
2吴飞华,金剑,肖忠革,金芝贵,诸慧.肺动脉高压的药物治疗及其进展[J].现代中西医结合杂志,2010,19(14):1815-1817. 被引量：6
-
3高从荣,周汝元.血管内皮功能障碍与肺动脉高压[J].中国心血管病研究,2006,4(12):947-949. 被引量：6
-
4陈金平,仇新军,于华,张志英,刘玉静.坎地沙坦联合复方丹参滴丸治疗高血压左心室肥厚[J].临床误诊误治,2013,26(1):66-69. 被引量：17
-
5张影,李雪峰,姜春萌,王朝晖.RANTES与幽门螺杆菌感染[J].国际消化病杂志,2006,26(4):243-246. 被引量：1
-
6程金涛.细胞因子与糖尿病视网膜病变[J].山东大学基础医学院学报,2003,17(2):115-117. 被引量：1
-
7宝群,孔祥雷,崔美玉.霉酚酸酯对糖尿病大鼠肾组织T细胞浸润的影响[J].国际泌尿系统杂志,2013,33(5):644-648.
-
8乔玉宏,王薇洁,付蓉.血小板参数的改变与糖尿病患者微血管病变的探讨[J].实用医技杂志,2003,10(9):990-990. 被引量：1
-
9邹晓月.糖尿病患者血小板数量及平均血小板体积参数变化的临床意义[J].江苏大学学报（医学版）,2005,15(4):343-343. 被引量：1
-
10陈芳,汤彦.肺动脉高压的药物治疗现状与进展[J].临床荟萃,2006,21(12):895-897. 被引量：2
